News Archives
SMHS is embarking on a strategic planning process, with the GW MFA, that will guide the combined goals of the SMHS/GW MFA for the first several years of the post-pandemic academic medical enterprise.
As news emerges that COVID-19 vaccine trials from U.S. pharmaceutical corporations Pfizer and Moderna are showing, in preliminary data, high-efficacy rates, a new question is being asked: What comes next?
A recent study by GW physicians on the severity of acute respiratory viral adverse events related to antirheumatic disease therapies found that some therapies may be associated with increased respiratory viral events while others don’t show increased frequency.
Concern over safe traveling during the COVID-19 pandemic is making many think twice about getting together with family or a winter getaway during the upcoming holiday season.
While COVID-19 infected patients should be treated with standard anticoagulation therapies, such as blood thinning medication, a new study by researchers at the George Washington University shows that anticoagulating patients at higher doses, without traditional medical indications to do so, may be ineffective and even harmful.
When it comes to protecting health care workers, it’s not just personal protective equipment that’s needed but also emotional protections, according to an editorial co-authored by faculty members at the SMHS and published in the Annals of Emergency Medicine.
Pooja Lakshmin, MD, clinical assistant professor of psychiatry and behavioral sciences, joined The Kojo Nnamdi Show on WAMU-FM for a segment on how to cope with election stress and anxiety.
For the first time, the George Washington University (GW) School of Medicine and Health Sciences (SMHS) Reunion Weekend went fully virtual, with more than 330 attendees tuning in to lectures and events from the comfort of their own homes across the country.
